NSG
GSK icon

Nalls Sherbakoff Group’s GSK GSK Stock Holding History

Nalls Sherbakoff Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$15.8K Buy
322
+232
+258% +$10.8K 0.01% 296
2025
Q3 		$3.88K Hold
90
– – ﹤0.01% 369
2025
Q2 		$3.46K Hold
90
– – ﹤0.01% 371
2025
Q1 		$3.49K Buy
+90
New +$3.29K ﹤0.01% 355
2018
Q4 		$4K Buy
+90
New +$4.43K 0.01% 320

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nalls Sherbakoff Group's GSK Position: Q4 2025 in Review

Nalls Sherbakoff Group increased its GSK (GSK) stake by 258% in Q4 2025, buying an estimated $10.8K and bringing the position to 322 shares worth $15.8K. The position accounts for 0.01% of the portfolio, ranked #296.

Nalls Sherbakoff Group first reported a position in GSK in Q4 2018 and has held it in 5 quarters since. 996 funds tracked by Wall St. Rank hold GSK as of Q4 2025.

  • Nalls Sherbakoff Group held 322 shares of GSK worth $15.8K as of Q4 2025.
  • Nalls Sherbakoff Group bought 232 GSK shares in Q4 2025, an estimated $10.8K.
  • GSK made up 0.01% of Nalls Sherbakoff Group's portfolio in Q4 2025, its #296 holding.
  • Nalls Sherbakoff Group first reported a position in GSK in Q4 2018 and has held it in 5 quarters since.
  • 996 funds tracked by Wall St. Rank held GSK as of Q4 2025.

Based on Nalls Sherbakoff Group's 13F filing for Q4 2025, filed 12 Mar 2026.